Johnson Fistel, PLLP, is investigating potential violations of federal and state securities laws by certain officers and directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who have held shares continuously since before certain dates may have standing to hold these companies harmless from the alleged harm caused by their officers and directors by making them personally responsible. You may also be able to assist in reforming each company’s corporate governance to prevent future wrongdoing.

If you have held Treace Medical Concepts, Inc.  shares continuously since prior to May 8, 2023, you may have standing to hold Skyworks harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing.

Complaint Allegations
A previously filed securities class action complaint alleges Defendants made false or misleading statements concerning the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose that: (1) competition impacted the demand for and utilization of Treace Medical’s primary product, the Lapiplasty® 3D Bunion Correction® System; and (2) as a result, Treace Medical’s revenue declined and the Company needed to accelerate its plans to offer an alternative product to osteotomy (a surgical procedure involving the cutting and realigning of bone to improve its position or function).